Primary breast tumours but not lung metastases induce protective anti-tumour immune responses after Treg-depletion
Lauder, S. N.
AffiliationDivision of Infection and Immunity, Cardiff University School of Medicine, SIURI, Cardiff, CF14 4XN, UK.
MetadataShow full item record
AbstractAlthough metastatic disease is responsible for the majority of cancer deaths, tests of novel immunotherapies in mouse tumour models often focus on primary tumours without determining whether these therapies also target metastatic disease. This study examined the impact of depleting Foxp3(+) regulatory T cells (Treg), on lung metastases, using a mouse model of breast cancer. After Treg-depletion, generation of an immune response to the primary tumour was a critical determinant for limiting development of metastasis. Indeed, resection of the primary tumour abrogated any effect of Treg-depletion on metastases. In addition, whilst the immune response, generated by the primary tumour, prevented metastases development, it had little impact on controlling established disease. Collectively, the data indicate that metastatic cells in the lung are not controlled by immune responses induced by the primary tumour. These findings indicate that targeting Tregs alone will not suffice for treating lung metastases.
CitationE. Hughes, S. N. Lauder, K. Smart et al. Primary breast tumours but not lung metastases induce protective anti-tumour immune responses after Treg-depletion. Cancer Immunol Immunother. 2020.
JournalCancer Immunology Immunotherapy
- Higher densities of Foxp3<sup>+</sup> regulatory T cells are associated with better prognosis in triple-negative breast cancer.
- Authors: Yeong J, Thike AA, Lim JC, Lee B, Li H, Wong SC, Hue SS, Tan PH, Iqbal J
- Issue date: 2017 May
- Regulatory T cells in breast cancer as a potent anti-cancer therapeutic target.
- Authors: Hashemi V, Maleki LA, Esmaily M, Masjedi A, Ghalamfarsa G, Namdar A, Yousefi M, Yousefi B, Jadidi-Niaragh F
- Issue date: 2020 Jan
- Selective depletion of Foxp3+ regulatory T cells improves effective therapeutic vaccination against established melanoma.
- Authors: Klages K, Mayer CT, Lahl K, Loddenkemper C, Teng MW, Ngiow SF, Smyth MJ, Hamann A, Huehn J, Sparwasser T
- Issue date: 2010 Oct 15
- Increase in activated Treg in TIL in lung cancer and in vitro depletion of Treg by ADCC using an antihuman CCR4 mAb (KM2760).
- Authors: Kurose K, Ohue Y, Sato E, Yamauchi A, Eikawa S, Isobe M, Nishio Y, Uenaka A, Oka M, Nakayama E
- Issue date: 2015 Jan
- Depletion of regulatory T cells by anti-GITR mAb as a novel mechanism for cancer immunotherapy.
- Authors: Coe D, Begom S, Addey C, White M, Dyson J, Chai JG
- Issue date: 2010 Sep